168 related articles for article (PubMed ID: 24906955)
1. The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy.
Chambers AE; Mills WE; Mercadé I; Crovetto F; Crispi F; Bodi LR; Pugia M; Mira A; Lasalvia L; Banerjee S; Casals E; Gratacos E
BMC Pregnancy Childbirth; 2014 Jun; 14():197. PubMed ID: 24906955
[TBL] [Abstract][Full Text] [Related]
2. Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down's syndrome, preterm delivery and preeclampsia.
Chambers AE; Griffin C; Naif SA; Mills I; Mills WE; Syngelaki A; Nicolaides KH; Banerjee S
Reprod Biol Endocrinol; 2012 Dec; 10():113. PubMed ID: 23245345
[TBL] [Abstract][Full Text] [Related]
3. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
4. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
5. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A.
Spencer K
BJOG; 2001 Oct; 108(10):1043-6. PubMed ID: 11702835
[TBL] [Abstract][Full Text] [Related]
6. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
[TBL] [Abstract][Full Text] [Related]
7. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
8. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
9. Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screening.
Bellver J; Casanova C; Garrido N; Lara C; Remohà J; Pellicer A; Serra V
Fertil Steril; 2013 Nov; 100(5):1314-20. PubMed ID: 23891271
[TBL] [Abstract][Full Text] [Related]
10. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
Crossley JA; Aitken DA; Cameron AD; McBride E; Connor JM
BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646
[TBL] [Abstract][Full Text] [Related]
11. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
12. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
13. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
[TBL] [Abstract][Full Text] [Related]
14. First trimester screening for Down's syndrome using maternal serum PAPP-A and free beta-hCG in combination with fetal nuchal translucency thickness.
Biagiotti R; Brizzi L; Periti E; d'Agata A; Vanzi E; Cariati E
Br J Obstet Gynaecol; 1998 Aug; 105(8):917-20. PubMed ID: 9746387
[TBL] [Abstract][Full Text] [Related]
15. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
16. The best marker combination using the integrated screening test approach for detecting various chromosomal aneuploidies.
Maymon R; Sharony R; Grinshpun-Cohen J; Itzhaky D; Herman A; Reish O
J Perinat Med; 2005; 33(5):392-8. PubMed ID: 16238533
[TBL] [Abstract][Full Text] [Related]
17. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
18. Importance of the integrated test in the Down's syndrome screening algorithm.
Springer D; Loucky J; Tesner P; Cutka D; Stejskal D; Gregor V; Zima T
J Med Screen; 2018 Sep; 25(3):114-118. PubMed ID: 29575979
[TBL] [Abstract][Full Text] [Related]
19. Second trimester serum tests for Down's Syndrome screening.
Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
[TBL] [Abstract][Full Text] [Related]
20. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K; Noble P; Snijders RJ; Nicolaides KH
Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
